
QUESTION:
Thoughts about completing a wean for infants as young as 8 months? (this patient I’m considering a thickener wean with is 12 months gestational age, 8 months correct, ex 22-weeker)
How do you manage nipple flow rates as you progress through the weaning process? i.e., patient is on a level 4 nipple, consuming formula thickened with 1 tsp per fluid oz.
What if the patient takes varying amounts of formula per feed? i.e., patient will sometimes consume 4 oz then the next feed, will consume 5 oz. I work primarily with low-income families in which parents use WIC, so I’m trying to prevent them from wasting formula. The study I’m referring to (Wolter et al 2018) uses 6 oz in their recipe.
I’m fairly new to utilizing this process in my practice.
CATHERINE’S ANSWER:
This infant sounds quite complex. I am wondering about the swallowing pathophysiology objectified in radiology that led to the need for thickening and how precarious that physiology was, even with thickening. The majority of our former 22 weekers have enduring multiple complex comorbidities and are often silent aspirators. Within this high risk patient group we often find the weaning protocol doesn’t build in the objective data necessary to determine the true impact of a change in amount of thickener on swallowing physiology and therefore, on airway protection during the course of a true feeding. The objective data from a VFSS about the can be often surprising and indeed is often necessary for our very fragile extremely preterm infants with complex histories…. versus weaning based on subjective/clinical impressions only. The risk-benefit ratio of clinical weaning for each patient must be carefully determined, especially with former 22 weekers.
The team at Boston Children’s has provided us with a wealth of research to help inform our practice. This paper referenced below details the intervention—a protocol for weaning thickened fluids via clinical data. Its implications are far reaching, and its recommendations require critical thinking.
Wolter NE, Hernandez K, Irace AL, Davidson K, Perez JA, Larson K, Rahbar R. A Systematic Process for Weaning Children with Aspiration from Thickened Fluids. JAMA Otolaryngol Head Neck Surg. 2018 Jan 1;144(1):51-56.
Like any other protocol, the key, I think, is considering when to utilize a protocol as a guide, and considering when not to; that is, when doing so may adversely affect the risk-benefit ratio. My physician mentors over the years have referred to this process as the “art and science of medicine”. It requires us to ask how we thoughtfully apply the findings of any study to our clinical reasoning for each patient individually, to minimize risk of adverse events.
Clearly our repeat studies according to the AAP must be completed with thoughtful justification and careful attention to risk-benefit ratio, especially with infants. It is best practice as stated in the article that “children should be transitioned to non-thickened diets as soon as it is safe to do so.”
However, reducing fluid thickness solely “based on a patient’s’ clinical response” is worrisome to me.
In pediatrics, like in adult care, patient A is not the same as patient B, even though they both have been placed on thickened liquids for clinically sound reasons. Those infants/children with more complex co-morbidities, those who silently aspirated, and those with more precarious swallowing pathophysiology would potentially have greater risk for airway invasion with changes based on clinical data alone. And there may not be clinical suspicion that the wean increases risk, as the weaning protocol proceeds. Universal application of the weaning protocol without a very clear consideration regarding these fragile high-risk feeders may inadvertently increase risk for airway invasion.
Duncan et al in their 2018 study (Duncan, D. R., Mitchell, P. D., Larson, K., & Rosen, R. L. (2018). Presenting signs and symptoms do not predict aspiration risk in children. The Journal of Pediatrics, 201, 141-146) reported that “Presenting symptoms are varied in patients with aspiration and cannot be relied upon to determine which patients have aspiration on VFSS. The CFE (clinical feeding evaluation) does not have the sensitivity to consistently diagnose aspiration”. Their findings would likely apply to post-swallow study decisions made without benefit of objective data, and that is worrisome.
Most recently, a team at Boston Children updated its 2019 paper on thickening considerations (see citation below), and among their recommendations was this statement:
“Implementation of a systematic weaning protocol may also result in a reduction in instrumental assessments for the patient which may reduce their exposure to ionizing radiation if re-evaluating via the videofluoroscopic swallow study. However, providers must remain cautious if using this approach in infants and young children with silent aspiration, given the difficulty in monitoring symptom change while weaning in these patients…The balance between viscosity and flow rate in aerodigestive patients with oropharyngeal dysphagia needs to be based on instrumental assessment of swallow safety such as videofluoroscopic swallow study.”
Duncan, D. R., Jalali, L., & Williams, N. (2024). Gastrointestinal Considerations When Thickening Feeds Orally and Enterally. Pediatric Aerodigestive Medicine: An Interdisciplinary Approach, 1-35.
Pados (2019, see citation below) further highlights the importance of assessing a feeding regimen under instrumental assessment: “When thickening of liquids is indicated, providers and families need data obtained from an instrumental assessment to guide evidence based decision-making about the safest thickened liquid consistency and type of nipple to offer to maintain a flow rate that is safe for the infant” (Pados BF, Park J, Dodrill P. Know the flow: Milk flow rates from bottle nipples used in the hospital and after discharge. Adv Neonatal Care. 2019;19(1):32–41).
Perhaps most worrisome is the possible implication from Wolters’ conclusions is the im0plication that the value of a VFSS is to identify bolus misdirection and aspiration, rather than to objectify swallowing physiology and pathophysiology as a basis for optimal interventions and their modification. The risk-benefit ratio of a repeat VFSS must indeed be carefully considered, but we must also consider the critical impact of that objective data, about physiology, on any changes in interventions we might consider.
The more I learn, the less black and white answers I have, and I think that is good. For each patient, we will need to continue to develop an algorithm for that patient, that best minimizes risk, in the setting of that child’s unique co-morbidities, history, and the nature of the swallowing pathophysiology objectified. Pausing to consider all the pieces and reflect, will always be the key. I hope this is helpful.